IL27 and neoplasm: In-vivo, LLC-MUT-expressing tumors grew faster than either WSX1 or GFP cohorts, excluding the role of IL27 as a tumor promoter (Figure 2b), suggesting that IL27 signaling in tumors may inhibit tumor growth rather than promote tumor growth.